Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

BES and BENSPM claimed as vascular proliferative disorders treatment

July 26, 1996

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996

Pierre Fabre reports antioxidants

July 26, 1996

Leukocyte elastase inhibitors reported by Sanofi Winthrop

July 26, 1996

Tryptase inhibitors described as immune-based inflammatory disorders treatment

July 26, 1996

Bifemelane claimed for cerebrovascular disorders treatment

July 26, 1996

Immunex issued U.S. patent for Lerk-7

July 26, 1996

CP-122638: Pfizer's potential treatment for non-migraine emesis

July 26, 1996

5-HT3/NK1 antagonist combination effective in emesis treatment and prevention

July 26, 1996

Vanderbilt University describes ligands for 5-HT3 receptors

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...